A clinical trial for LCA1 (Gucy2D mutations) might soon begin at Scheie Eye institute in Philadelphia!
To learn more and see if you can be a candidate, contact Dr. Jacobson (phone 215-662-9981, email jacobsos@mail.med.upenn.edu). He will first require the necessary medical records to be sent to him, then patients will be seen in Philadelphia for additional tests.
0 comments:
Post a Comment